Here, we established this pan-cancer analysis to systematically elucidate the role of PSMB9 in orchestrating tumor immune processes and its potential as a novel predictive biomarker for T cell-based immunotherapy responses in diverse malignancies. The gene discussed is PSMB9; the disease is cancer.